CellWell record HH-19672
Therapeutic strategies targeting the endothelial glycocalyx
Machin DR; Sabouri M; Zheng X; Donato AJ
Current opinion in clinical nutrition and metabolic care ยท 2023
In plain language
High sodium, kidney disease, diabetes, COVID-19, and sepsis all degrade the endothelial glycocalyx -- heparin and hyaluronan supplementation may restore the barrier.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-19672
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.